LOS ANGELES--(BUSINESS WIRE)--ImmunoCellular Therapeutics, Ltd. (“ImmunoCellular” or the “Company”) (OTCBB: IMUC), a biotechnology company focused on the development of novel immune-based therapies, today announced that John Yu, MD, Chairman, will deliver an oral presentation at the Annual Meeting of the Congress of Neurological Surgeons. The abstract titled, “A Multi-Epitope Pulsed Dendritic Cell Vaccine (ICT-107) Targeting Glioblastoma Cancer Stem Cells Reduces the Cancer Stem Cell Population in Recurrent Tumor and Is Associated with Increased Progression-free Survival,” will be presented at 2:54 p.m. today in room 151B at the Washington Convention Center in Washington, D.C.
